The present study investigated the clinicopathological characteristics and expression of biomarkers of risk factors of HCC recurrence after liver resection, including FGFR2, VEGF, TRAIL-R1, and TRAIL-R2, in patients with HCC. The gene discussed is FGFR2; the disease is hepatocellular carcinoma.